Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Auro Vaccines RSV vaccine
- Development stage
- Preclinical
- Lead developer
- Auro Vaccines
- Modality
- Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
01
Overview
Auro Vaccines RSV vaccine is a viral vector vaccine candidate currently in preclinical development for the prevention of respiratory syncytial virus (RSV) infection. Utilizing the proprietary VesiculoVax™ platform, the vaccine employs an engineered, replication-competent vesicular stomatitis virus (VSV) vector to deliver RSV antigens. The VSV vector is a negative-strand, non-segmented RNA virus modified to express these antigens in their authentic form, which is intended to trigger a robust immune response and the production of neutralizing antibodies. The vaccine is specifically designed to address the significant morbidity associated with RSV in vulnerable populations, such as young children and older adults, and is being evaluated for immunogenicity and efficacy in various animal models.
- Other names
- VesiculoVax RSV vaccineVSV-based RSV vaccine
Beyond the preview
Go deeper on Auro Vaccines RSV vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Auro Vaccines RSV vaccine.